Financial News
All News about Arrowhead Pharma
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/lab-3498584_1920.image_by_fernando_zhiminaicela_from_pixabay_.jpg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_931.png)
![](https://mms.businesswire.com/media/20210706005215/en/523535/5/ah_logo_cmyk.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_237.png)
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2021/july/mmc/midday-market-stats-july-2.png?sfvrsn=165fd706_2)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://www.investors.com/wp-content/uploads/2019/07/stock-pharmaceutical-opioids-01-shutter.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
Mid-Day Market Update: Dow Surges Over 100 Points; Arrowhead Pharmaceuticals Shares Plummet
July 02, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://g.foolcdn.com/editorial/images/632531/3-frowning-people-looking-at-a-laptop.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_907.png)
![](https://mms.businesswire.com/media/20210702005064/en/523535/5/ah_logo_cmyk.jpg)
Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study
July 02, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20210630005257/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20210626005001/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20210625005037/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20210623005347/en/523535/5/ah_logo_cmyk.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/nerve-cell-2213009_1920_31.jpg)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_769.png)
![](https://mms.businesswire.com/media/20210621005240/en/886346/5/ARWR_Logo.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
![](https://www.investors.com/wp-content/uploads/2020/04/Stock-Vertex-04-shutt.jpg)
![](https://mms.businesswire.com/media/20210603005276/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20210602005398/en/523535/5/ah_logo_cmyk.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_357.png)
![](https://mms.businesswire.com/media/20210518005076/en/523535/5/ah_logo_cmyk.jpg)
Arrowhead Earns $10 Million Option Exercise Fee
May 18, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20210512005894/en/523535/5/ah_logo_cmyk.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.